These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3190811)

  • 1. Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation.
    Dietrich R; Brausse R; Benedikt G; Steinijans VW
    Arzneimittelforschung; 1988 Aug; 38(8A):1229-37. PubMed ID: 3190811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the in-vitro dissolution method used for a new sustained-release theophylline pellet formulation.
    Dietrich R; Brausse R; Bautz A; Diletti E
    Arzneimittelforschung; 1988 Aug; 38(8A):1220-8. PubMed ID: 3190810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.
    Benedikt G; Steinijans VW; Dietrich R
    Arzneimittelforschung; 1988 Aug; 38(8A):1203-9. PubMed ID: 3190808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo-in vitro correlations with sustained-release theophylline preparations.
    Ritschel WA; Koch HP; Alcorn GJ
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):609-18. PubMed ID: 6513678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
    Brockmeier D; von Hattingberg HM
    Arzneimittelforschung; 1982; 32(3):248-51. PubMed ID: 6896279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
    Keinke O
    Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
    Steinijans VW; Trautmann H; Sauter R; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to the specification of in-vitro dissolution boundaries based on regulatory requirements for bioequivalence.
    Steinijans VW; Dietrich R; Trautmann H; Sauter R; Benedikt G
    Arzneimittelforschung; 1988 Aug; 38(8A):1238-40. PubMed ID: 3190812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the pellet coating process used for a new sustained-release theophylline formulation.
    Dietrich R; Brausse R
    Arzneimittelforschung; 1988 Aug; 38(8A):1210-9. PubMed ID: 3190809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.
    Schulz HU; Karlsson S; Sahner-Ahrens I; Steinijans VW; Beier W
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):222-8. PubMed ID: 3583472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
    Miyazaki Y; Yakou S; Takayama K
    J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
    Brouwers J; Ingels F; Tack J; Augustijns P
    J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.